A reduced dose is suggested for patients with Persistent respiratory insufficiency, resulting from the potential risk of respiratory depression.Diazepam Tablets USP are contraindicated in clients with a recognized hypersensitivity to diazepam and, due to not enough sufficient scientific practical experience, in pediatric individuals under 6 months